AU5965399A - Pharmaceutically active composition - Google Patents

Pharmaceutically active composition

Info

Publication number
AU5965399A
AU5965399A AU59653/99A AU5965399A AU5965399A AU 5965399 A AU5965399 A AU 5965399A AU 59653/99 A AU59653/99 A AU 59653/99A AU 5965399 A AU5965399 A AU 5965399A AU 5965399 A AU5965399 A AU 5965399A
Authority
AU
Australia
Prior art keywords
pharmaceutically active
active composition
composition
pharmaceutically
active
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU59653/99A
Other languages
English (en)
Inventor
Andreas Bockelmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU5965399A publication Critical patent/AU5965399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7004—Monosaccharides having only carbon, hydrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU59653/99A 1998-10-12 1999-10-11 Pharmaceutically active composition Abandoned AU5965399A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CH715/98 1998-10-12
CH71598 1998-10-12
PCT/CH1999/000482 WO2000021507A2 (de) 1998-10-12 1999-10-11 Pharmazeutisch wirksame zusammensetzung

Publications (1)

Publication Number Publication Date
AU5965399A true AU5965399A (en) 2000-05-01

Family

ID=4193483

Family Applications (1)

Application Number Title Priority Date Filing Date
AU59653/99A Abandoned AU5965399A (en) 1998-10-12 1999-10-11 Pharmaceutically active composition

Country Status (2)

Country Link
AU (1) AU5965399A (de)
WO (1) WO2000021507A2 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2274842T3 (es) * 2001-08-18 2007-06-01 Cognis Ip Management Gmbh Mezclas de principios activos.
US7582674B2 (en) 2003-05-27 2009-09-01 Dsm Ip Assets B.V. Nutraceutical compositions and use thereof
EP1896041A2 (de) * 2005-06-29 2008-03-12 Mars, Incorporated Behandlung von okklusiver thrombose
ES2378896T3 (es) 2005-09-15 2012-04-18 Otsuka Pharmaceutical Co., Ltd. Combinación de fármacos que contiene Probucol y un derivado de tetrazolilalcoxi-dihidrocarbostirilo con efectos inhibidores del superóxido
CH701576B1 (de) * 2007-04-20 2011-02-15 Andreas Bockelmann Wirkstoffkombination zur Prophylaxe von okklusiven Gefässkrankheiten und Krebs.
GB0819959D0 (en) 2008-10-31 2008-12-10 Provexis Natural Products Ltd Fruit extracts
GB0819958D0 (en) * 2008-10-31 2008-12-10 Provexis Natural Products Ltd Therapeutic compositions
US20100255088A1 (en) * 2009-04-06 2010-10-07 Yoel Ovil Method for delivering a combination of resveratrol and aspirin for use in treatment and prevention of vascular disease
US9446018B2 (en) 2009-07-10 2016-09-20 Sinphar Tian-Li Pharmaceutical Co., Ltd. (Hangzhou) Pharmaceutical composition for treating or preventing angina or myocardial infarction induced by myocardial ischemia
CN102321129B (zh) * 2011-07-14 2013-12-18 中国人民解放军第四军医大学 一种二苯乙烯苷注射剂及其制备工艺
AU2013252637B2 (en) 2012-04-23 2016-12-22 Provexis Natural Products Limited Use of tomato extract as antihypertensive agent and process for making water soluble sugar free tomato extract
DE102012025005A1 (de) * 2012-12-20 2014-06-26 Herbalist & Doc Gesundheitsgesellschaft Mbh Verbesserte Thrombocytenaggregationshemmung mittels Kombination von NSAR und Veratrol oder dessen Analogen
GB201223365D0 (en) 2012-12-24 2013-02-06 Provexis Natural Products Ltd Compositions
KR20230048169A (ko) 2016-11-02 2023-04-10 프로벡시스 내추럴 프로덕츠 리미티드 대기 오염의 악영향을 막는 수용성 토마토 추출물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3340873A1 (de) * 1983-11-11 1985-05-23 ARTESAN GmbH Fabrik chemisch-pharmazeutischer Präparate, 3130 Lüchow Verwendung von magnesium-salicylat oder magnesium-acetylsalicylat
JPH0697842B2 (ja) * 1989-01-10 1994-11-30 東光株式会社 スイッチングレギュレータ
RU2022557C1 (ru) * 1989-09-04 1994-11-15 Украинский научно-исследовательский институт терапии Способ лечения стенокардии
DE59712694D1 (de) * 1997-04-18 2006-08-24 Fritz Stanislaus Stabilisiertes arzneimittel enthaltend cysteinylderivate
AU6462899A (en) * 1998-08-06 2000-02-28 Vascular Biotech Gmbh Combination of active substances, especially for the prophylaxis and therapy of ischaemic organic lesions and reperfusion syndromes

Also Published As

Publication number Publication date
WO2000021507A3 (de) 2000-07-27
WO2000021507A2 (de) 2000-04-20

Similar Documents

Publication Publication Date Title
SG115489A1 (en) Pharmaceutically active morpholinol
GB9823101D0 (en) Pharmaceutically active compounds
AU4477597A (en) New pharmaceutically active compounds
AU1225000A (en) Combined pharmaceutical estrogen-androgen-progestin
AU3743500A (en) Antistatic composition
AU5270499A (en) Formulations having probiotically active microorganisms
AU4318000A (en) Agarobiose-containing composition
GB9823102D0 (en) Pharmaceutically active compounds
AU1887401A (en) Medicinal composition
AU1290501A (en) Composition
AU4905499A (en) Topical aciclovir formulations
AU5965399A (en) Pharmaceutically active composition
AU752953C (en) Adding pharmaceutically active compounds to substrates
AU2080199A (en) New pharmaceutically active compounds
AU1969800A (en) Combination of active agents
AU6036100A (en) New pharmaceutically active compounds
AU4143397A (en) New pharmaceutically active compounds
AUPP332898A0 (en) Pharmaceutical composition
AU3538699A (en) Novel physiologically active substances
AU6310600A (en) Composition
AU5567600A (en) Hairdye composition
AU4143297A (en) New pharmaceutically active compounds
AU2647099A (en) Active splitter
AU6610500A (en) Antidiscoloration composition
AU2648899A (en) Composition

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase